In vitro activity of rodogyl against putative periodontopathic bacteria.
The minimal inhibitory concentrations of Rodogyl (composite tablet of metronidazole and spiramycin), metronidazole-spiramycin mixture, spiramycin, metronidazole, and tetracycline were determined for selected putative periodontopathic microorganisms. Rodogyl was active against almost all strains, including Bacteroides species and the anaerobic spirochetes. Synergism of the component drugs in the Rodogyl combination was noted against Propionibacterium species. Spiramycin activity against Actinomyces species was enhanced in the presence of metronidazole.
D001419:Bacteria / Q000187:drug effects*; D004338:Drug Combinations / Q000494:pharmacology; D006801:Humans; D007933:Leucomycins / Q000494:pharmacology*; D008795:Metronidazole / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D010518:Periodontitis / Q000382:microbiology*; D015572:Spiramycin; D013752:Tetracycline / Q000494:pharmacology
D004338:Drug Combinations; D007933:Leucomycins; D008795:Metronidazole; D015572:Spiramycin; C039503:Rodogyl; D013752:Tetracycline